| Nov 12 2024 |
European Medtech Companies: Why a U.S. Centric Patent Strategy is Essential for Long-Term Success |
Foley & Lardner LLP |
| Nov 11 2024 |
Foley Automotive Update 11 November 2024 |
Foley & Lardner LLP |
| Nov 11 2024 |
The Italian Law Implementing the EU MiCar Regulation: A "MiFIDisation" of Crypto-Assets? |
K&L Gates LLP |
| Nov 11 2024 |
A Step Closer to CSRD’s Non-EU Group Reporting Standards |
Proskauer Rose LLP |
| Nov 11 2024 |
Competition Currents | November 2024 |
Greenberg Traurig, LLP |
| Nov 11 2024 |
EU Court Ruling Expands Copyright Protection for International Works of Applied Art |
Greenberg Traurig, LLP |
| Nov 11 2024 |
To Be Or Not To Be: Self-Revocation of Seminal European Patents Creates New Uncertainty In CRISPR IP Space |
Proskauer Rose LLP |
| Nov 11 2024 |
ESG Ratings Regulation Progresses – Asset Managers to Keep Watch |
Proskauer Rose LLP |
| Nov 8 2024 |
The BR Privacy & Security Download: November 2024 |
Blank Rome LLP |
| Nov 8 2024 |
New Cyber Security Rules for US Technology Companies Operating in the EU |
Womble Bond Dickinson (US) LLP |
| Nov 8 2024 |
Authorities Providing Some Flexibility in Complying with CBAM Reporting Obligations |
Squire Patton Boggs (US) LLP |
| Nov 7 2024 |
How Legitimate Is Your Business Interest? The EDPB Has Some Thoughts |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 6 2024 |
EU Artificial Intelligence Act – Business Implications and Compliance Strategies |
Greenberg Traurig, LLP |
| Nov 6 2024 |
EDPB Adopts First Report Under Data Privacy Framework |
Hunton Andrews Kurth |
| Nov 6 2024 |
Regulation Round Up: October 2024 |
Proskauer Rose LLP |
| Nov 6 2024 |
Guidelines on Funds’ Names Using ESG or Sustainability-Related Terms |
Squire Patton Boggs (US) LLP |
| Nov 5 2024 |
The Difference Between EU and US AI Regulation: A Foreshadowing of the Future of Litigation in AI |
CMBG3 Law |
| Nov 5 2024 |
EU Sets Definitive Countervailing Duties on Imports of Chinese Electric Vehicles |
Squire Patton Boggs (US) LLP |
| Nov 4 2024 |
EC Committee Issues Final Opinion on New Coating for Titanium Dioxide (Nano Form) |
Bergeson & Campbell, P.C. |
| Nov 4 2024 |
European PFAS Update – October 2024 |
Squire Patton Boggs (US) LLP |
| Nov 1 2024 |
RAC and SEAC Will Continue to Evaluate Proposed PFAS Restriction in 2025 |
Bergeson & Campbell, P.C. |
| Nov 1 2024 |
EDPB Provides Insight for Use of Tracking Tools |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 1 2024 |
Delays in REACH Procedures: EU Ombudsman Identifies Maladministration |
Squire Patton Boggs (US) LLP |
| Oct 31 2024 |
DORA-Check |
McDermott Will & Emery |
| Oct 30 2024 |
Regional Challenges in Regulating Medical Product AI [Video] |
Mintz |
| Oct 30 2024 |
SaaS Resellers: High Court Rules on Protection for SaaS Resellers Under Commercial Agents Regulations |
Squire Patton Boggs (US) LLP |
| Oct 29 2024 |
Updates on Foreign Direct Investments: The European Commission Publishes its Fourth Annual Report on the Screening of Foreign Direct Investments in the European Union and Plans to Revise the EU FDI Screening Regulation |
K&L Gates LLP |
| Oct 29 2024 |
Candidate Commissioners Roswall and Séjourné Commit to 2025 REACH Revision |
Squire Patton Boggs (US) LLP |
| Oct 28 2024 |
Navigating the New UAE Competition Law: Moving Towards EU Principles? Part 4—UAE Prohibition on Abuse of Dominant Position and Article 102 of the Treaty on the Functioning of the European Union (TFEU) |
K&L Gates LLP |
| Oct 28 2024 |
CJEU Rules on Scope of Legitimate Interest Basis under the GDPR |
Hunton Andrews Kurth |
| Oct 25 2024 |
EU’s New Export Due Diligence Guidelines: Keeping Tabs on Cyber-Surveillance Technology |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 25 2024 |
The Stony Road to De-Fragmentation of EU Foreign Direct Investment Control (FDI) |
Squire Patton Boggs (US) LLP |
| Oct 25 2024 |
CSRD: French Prime Minister’s Declarations – A Realistic Step Backwards? |
Squire Patton Boggs (US) LLP |
| Oct 24 2024 |
Brussels Regulatory Brief: October 2024 |
K&L Gates LLP |
| Oct 24 2024 |
Counting Down to DORA Compliance: Recent Developments |
Katten |
